The purpose of the study:
To evaluate how safe and effective an investigational medication will be as a possible Lupus treatment, when compared with placebo (inactive substance). Participants may be able to continue taking stable doses of some standard lupus medications.
Duration:
Up to 1 year
Number of visits:
18-22 visits
Compensation:
Up to $1090
Qualifications and Notes:
Qualified participants must be 18 yrs of age or older and have been diagnosed with SLE (Systemic Lupus Erythematosus).
Request Study Information!
859.225-5672
Or fill out our quick form below
